Eli Lilly Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 06 May 26 | Sellzł56,736,813 | Lilly Endowment Inc. | Company | 15,828 | zł3,587.55 | |
| 07 Jan 26 | Sellzł1,161,666,724 | Lilly Endowment Inc. | Company | 292,148 | zł4,023.87 | |
| 05 Jan 26 | Sellzł5,425,323 | Lilly Endowment Inc. | Company | 1,390 | zł3,903.11 | |
| 29 Dec 25 | Sellzł14,018,337 | Lilly Endowment Inc. | Company | 3,593 | zł3,901.57 | |
| 24 Dec 25 | Sellzł11,141,670 | Lilly Endowment Inc. | Company | 2,869 | zł3,883.51 | |
| 25 Nov 25 | Sellzł652,083,503 | Lilly Endowment Inc. | Company | 162,693 | zł4,058.64 | |
| 24 Nov 25 | Sellzł559,132,806 | Lilly Endowment Inc. | Company | 142,307 | zł3,947.72 | |
| 21 Nov 25 | Sellzł411,472,421 | Lilly Endowment Inc. | Company | 105,326 | zł3,934.31 | |
| 20 Nov 25 | Sellzł143,341,158 | Lilly Endowment Inc. | Company | 37,148 | zł3,872.34 | |
| 19 Nov 25 | Sellzł645,718,721 | Lilly Endowment Inc. | Company | 167,526 | zł3,868.77 | |
| 18 Nov 25 | Sellzł228,355,040 | Lilly Endowment Inc. | Company | 60,213 | zł3,810.17 | |
| 17 Nov 25 | Sellzł37,161,285 | Lilly Endowment Inc. | Company | 9,886 | zł3,762.08 | |
| 14 Nov 25 | Sellzł668,109,524 | Lilly Endowment Inc. | Company | 178,295 | zł3,755.52 | |
| 13 Nov 25 | Sellzł174,394,469 | Lilly Endowment Inc. | Company | 46,606 | zł3,747.41 | |
| 12 Nov 25 | Sellzł1,126,996,223 | Lilly Endowment Inc. | Company | 305,000 | zł3,731.18 | |
| 11 Nov 25 | Sellzł1,079,143,823 | Lilly Endowment Inc. | Company | 300,000 | zł3,645.47 | |
| 05 Nov 25 | Sellzł761,846,470 | Lilly Endowment Inc. | Company | 219,474 | zł3,539.13 | |
| 04 Nov 25 | Sellzł1,775,124 | Lilly Endowment Inc. | Company | 526 | zł3,374.76 | |
| 03 Nov 25 | Sellzł984,201,167 | Lilly Endowment Inc. | Company | 300,000 | zł3,324.83 | |
| 31 Oct 25 | Sellzł960,425,228 | Lilly Endowment Inc. | Company | 301,342 | zł3,209.72 | |
| 10 Oct 25 | Sellzł11,591,683 | Lilly Endowment Inc. | Company | 3,658 | zł3,169.34 | |
| 09 Oct 25 | Sellzł33,274,505 | Lilly Endowment Inc. | Company | 10,602 | zł3,156.07 | |
| 08 Oct 25 | Sellzł315,792,108 | Lilly Endowment Inc. | Company | 101,420 | zł3,134.67 | |
| 07 Oct 25 | Sellzł82,777,707 | Lilly Endowment Inc. | Company | 26,795 | zł3,089.30 | |
| 06 Oct 25 | Sellzł498,119,013 | Lilly Endowment Inc. | Company | 161,183 | zł3,110.34 | |
| 03 Oct 25 | Sellzł583,988,660 | Lilly Endowment Inc. | Company | 192,404 | zł3,070.27 | |
| 02 Oct 25 | Sellzł336,869,491 | Lilly Endowment Inc. | Company | 112,596 | zł3,036.89 | |
| 01 Oct 25 | Sellzł1,033,918,314 | Lilly Endowment Inc. | Company | 351,015 | zł3,026.18 | |
| 30 Sep 25 | Sellzł315,649,779 | Lilly Endowment Inc. | Company | 113,694 | zł2,786.21 | |
| 19 Sep 25 | Sellzł65,563,710 | Lilly Endowment Inc. | Company | 23,665 | zł2,775.50 | |
| 18 Sep 25 | Sellzł294,754,338 | Lilly Endowment Inc. | Company | 106,626 | zł2,773.09 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 1,735 | 0.000195% |
| State or Government | 892,314 | 0.1% |
| Individual Insiders | 1,516,706 | 0.17% |
| General Public | 105,653,724 | 11.9% |
| Institutions | 783,294,579 | 87.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 90,376,978 | zł396.6b | -1.65% | 100.0% | |||
| 67,540,400 | zł296.4b | 1.75% | 0.88% | |||
| 58,121,179 | zł255.1b | 0.24% | 1.01% | |||
| 51,120,779 | zł224.4b | 0% | 32.71% | |||
| 42,966,681 | zł188.6b | -8.22% | 1.87% | |||
| 36,215,754 | zł158.9b | 1.7% | 1.14% | |||
| 25,969,466 | zł114.0b | 7.32% | 1.32% | |||
| 20,859,217 | zł91.5b | -0.56% | 1.1% | |||
| 20,310,858 | zł89.1b | 0.59% | 1.09% | |||
| 15,018,780 | zł65.9b | -6.2% | 1.37% | |||
| 13,427,061 | zł58.9b | 0.52% | 2.31% | |||
| 11,471,413 | zł50.3b | -5% | 0.78% | |||
| 11,075,316 | zł48.6b | -0.36% | 0.84% | |||
| 10,759,188 | zł47.2b | 0% | 8.57% | |||
| 9,223,432 | zł40.5b | -0.46% | 6.48% | |||
| 8,796,866 | zł38.6b | -0.35% | 1.12% | |||
| 8,578,666 | zł37.6b | -7.85% | 0.84% | |||
| 5,899,282 | zł25.9b | 0% | 0.8% | |||
| 5,461,416 | zł24.0b | 7.91% | 3.66% | |||
| 5,426,474 | zł23.8b | -1.58% | 0.85% | |||
| 5,379,364 | zł23.6b | 1.62% | 1.09% | |||
| 5,352,135 | zł23.5b | -0.68% | 1.08% | |||
| 5,063,516 | zł22.2b | 4.64% | 1.72% | |||
| 4,889,563 | zł21.5b | -4.81% | 0.8% | |||
| 4,790,941 | zł21.0b | -5.57% | 1.12% |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/17 05:02 |
| End of Day Share Price | 2026/08/12 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eli Lilly and Company is covered by 53 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Emily Field | Barclays |
| Kerry Holford | Berenberg |